In Vitro Clonal Priming Data Suggests Mechanism for Lower Initial Vaccine Dose Yielding Increased Immunity in Astra-Zeneca Vaccine Trial | Zendy

AI Assistant Blog Pricing

Open Access

In Vitro Clonal Priming Data Suggests Mechanism for Lower Initial Vaccine Dose Yielding Increased Immunity in Astra-Zeneca Vaccine Trial

Author(s) -

Alan M. Dattner,

Frank Martiniuk,

William R. Levis

Publication year - 2021

Publication title -

journal of drugs in dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.701

H-Index - 62

ISSN - 1545-9616

DOI - 10.36849/jdd.6003

Subject(s) - medicine , priming (agriculture) , immunity , in vitro , astra , immunology , virology , immune system , genetics , biology , botany , germination , physics , quantum mechanics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.